Absci logo
Absci
ABSI | NASDAQ
Chart Builder DCF Calculator
$7.47
-$0.98 (-11.60%)
At close: Nov 16, 2026, 4:00 PM ET
$7.55
+$0.08 (+1.12%)
After-hours: Nov 16, 2026, 7:58 PM ET

Absci Company Profile

Company profile explained

Company Profile

Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.

Key Executives

Name Position
Sean McClain Founder, Chief Executive Officer, President & Director
Shelby Walker Chief Legal Officer
Zachariah Jonasson Chief Business Officer & Chief Financial Officer
Alexander Khan CVP of Finance & Head of Investor Relations
Christine Lemke Senior Vice President of Portfolio & Growth Strategy
Jeanne Schreuder SPHR Senior Vice President of People & Experience
Moetaz Albizem Senior Vice President of Clinical Operations
Ransi Somaratne FACC Chief Medical Officer
Todd Bedrick Senior Vice President & Chief Accounting Officer
Wen Sha Chief of Staff

Latest SEC Filings

Date Type Title
Oct 30, 2026 4 Filing
Oct 27, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 14, 2026 4 Filing
Oct 14, 2026 4 Filing
Oct 14, 2026 4 Filing
Sep 01, 2026 4 Filing
Aug 11, 2026 10-Q Quarterly Report
Aug 11, 2026 8-K Current Report
Aug 07, 2026 4 Filing
Aug 07, 2026 3 Filing
View All SEC Filings ➞
Absci
Absci logo
Country United States
IPO Date Jul 22, 2021
Industry Biotechnology
Sector Healthcare
Employees 140
CEO Sean McClain

Contact Details

18105 SE Mill Plain Boulevard Vancouver, Washington 98683 United States

Stock Details

Ticker Symbol ABSI
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001672688
CUSIP Number 00091E109
ISIN Number US00091E1091
SIC Code 8731

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.